134 related articles for article (PubMed ID: 12101778)
21. p53 and K-ras in radon-associated lung adenocarcinoma.
McDonald JW; Taylor JA; Watson MA; Saccomanno G; Devereux TR
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):791-3. PubMed ID: 8672998
[TBL] [Abstract][Full Text] [Related]
22. Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.
Hrasćan R; Pavelić K; Pavicić D; Krizanac S; Stajcer-Sittić V; Pecur L; Spaventi S; Klimpfinger M; Pavelić J
Anticancer Res; 1996; 16(6B):3761-6. PubMed ID: 9042254
[TBL] [Abstract][Full Text] [Related]
23. [Expression of tumor suppressor genes p16, p21 and p53 in a pair of lung adenocarcinoma cell lines with different metastasis potentials: Anip973 and AGZY83-a].
Wang B; Yan C; Wu Y; Gao H; Wang Q; Jin Y; Huang C; Zhang G; Fu S; Li P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):128-31. PubMed ID: 11295133
[TBL] [Abstract][Full Text] [Related]
24. [Molecular diagnosis of lung carcinoma].
Noguchi M
Rinsho Byori; 1994 Apr; 42(4):355-8. PubMed ID: 8176843
[TBL] [Abstract][Full Text] [Related]
25. [Molecular genetics of ovarian cancer].
Yanaihara N; Okamoto A; Takakura S; Yamada K; Ochiai K; Tanaka T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():441-8. PubMed ID: 15535284
[No Abstract] [Full Text] [Related]
26. Molecular genetics of bladder cancer: pathways of development and progression.
Knowles MA
Cancer Surv; 1998; 31():49-76. PubMed ID: 15281317
[No Abstract] [Full Text] [Related]
27. [Studies on genes associated with biologic behavior in human lung cancer].
Bai L; Sun Y; Li S
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):23-5. PubMed ID: 11263295
[TBL] [Abstract][Full Text] [Related]
28. [Molecular pathology of oncogenes and anti-oncogenes in diagnosis of colonic polyps].
Monden T; Morimoto H; Nakanishi H; Fukunaga M; Shimano T; Mori T
Nihon Rinsho; 1991 Dec; 49(12):88-96. PubMed ID: 1787590
[No Abstract] [Full Text] [Related]
29. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
30. [Mutations of ras and p53 genes in human non-small cell lung cancer cell lines and their clinical significance].
Mitsudomi T; Oyama T; Gazdar AF; Minna JD; Okabayashi K; Shirakusa T
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):944-7. PubMed ID: 1361656
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppressor genes involved in metastasis of lung and colorectal carcinomas.
Yokota J; Ookawa K; Nishikawa R; Sameshima Y
Princess Takamatsu Symp; 1991; 22():71-6. PubMed ID: 1844253
[TBL] [Abstract][Full Text] [Related]
32. Carcinogenic alterations in murine liver, lung, and uterine tumors induced by in utero exposure to ionizing radiation.
Lumniczky K; Antal S; Unger E; Wunderlich L; Hidvégi EJ; Sáfrány G
Mol Carcinog; 1998 Feb; 21(2):100-10. PubMed ID: 9496910
[TBL] [Abstract][Full Text] [Related]
33. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
34. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.
Lehman TA; Bennett WP; Metcalf RA; Welsh JA; Ecker J; Modali RV; Ullrich S; Romano JW; Appella E; Testa JR
Cancer Res; 1991 Aug; 51(15):4090-6. PubMed ID: 1855224
[TBL] [Abstract][Full Text] [Related]
35. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
[TBL] [Abstract][Full Text] [Related]
36. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
37. New molecular approaches to lung cancer: biological and clinical implications of P53, P16 and K-RAS studies.
Niklinska W; Chyczewski L; Niklinski J
Folia Histochem Cytobiol; 2001; 39(2):99-103. PubMed ID: 11374847
[TBL] [Abstract][Full Text] [Related]
38. [Oncogenes and suppressor genes in the genesis and progression of solid tumors in children].
Tonini GP; Mazzocco K; Scaruffi P
Pediatr Med Chir; 1994; 16(3):203-9. PubMed ID: 7971441
[TBL] [Abstract][Full Text] [Related]
39. MYCL1, FHIT, SPARC, p16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis.
Demopoulos K; Arvanitis DA; Vassilakis DA; Siafakas NM; Spandidos DA
J Cell Mol Med; 2002; 6(2):215-22. PubMed ID: 12169206
[TBL] [Abstract][Full Text] [Related]
40. Oncogenes and suppressor genes: their involvement in colon cancer.
Rigas B
J Clin Gastroenterol; 1990 Oct; 12(5):494-9. PubMed ID: 2229991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
